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A B S T R A C T
Purpose: To investigate the frequency and the association of vacA alleles, cagA, cagE and virB11 genes of
Helicobacter pylori from patients with gastric cancer, considering the clinic histopathological parameters.
Methods: One hundred and one gastric adenocarcinoma tissues were assessed by PCR to detect H. pylori
and vacA alleles, cagA, cagE and virB11. Results: The distribution of cases according to the presence of the
genes studied showed that the group containing vacA s1m1, cagA, cagE and virB11 H. pylori genes was
signiﬁcantly more frequent, followed by the group with at least one marker on the right side and left of
the island. They were also present in the early stages and were the most frequent in nearly all
histopathological grades. Conclusions: This study veriﬁed that vacAs1m1 and cag-PAI genes, cagA, cagE
and virB11 are important H. pylori markers for gastric cancer development. Also, this study corroborates
the importance of cagE and cagA together as cag-PAI marker.
 2011 Elsevier Ltd. 
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Gastric cancer is the fourth most common cancer and the
second leading cause worldwide of cancer deaths [1,2]. About two-
thirds of the cases occur in the developing world [3,4].
Adenocarcinoma, the most common gastric cancer type, has been
classiﬁed by Lauren according to the clinical and histological
features into two main types: diffuse and intestinal [5], which
differ in their molecular changes and they are considered distinct
tumors, having distinct carcinogenetic pathways [6,7].
Helicobacter pylori is one of the most important environmental
causative agents of gastric carcinoma. Over 50% of the population is
reported to be infected by H. pylori but only 1–2% will develop gastric
cancer [8]. The association of H. pylori with gastric cancer is strongest
for non-cardia cancer, and it holds for both intestinal and diffuse
histological types [9]. These observations indicate that besides the
host parasite relationship in gastric cancer development, there is a
need for studies to improve understanding of H. pylori itself. H. pylori
is one of the most genetically diverse pathogenic bacteria [10]. This
feature results in populations of bacteria with regional differences,
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Open access under the Elsevier OA license. of virulence [10,11]. However, there is evidence of distinct genetic
lineages that may have a role in its pathogenesis.
Some virulence factors of H. pylori are frequently associated
with the most serious clinical outcomes and pathogenic bacteria.
These include the cag pathogenicity island (cag-PAI), which has
about 31 genes, and the presence of allelic variation of the vacA
gene [11,12]. The vacA gene produces a 95-kDa homonym secreted
protein which induces apoptosis, partly by forming pores in the
mitochondrial and cytoplasm membrane, thereby allowing the
efﬂux of cytochrome c, inducing apoptosis and increases the
cellular permeability [13]. It also produces immunosuppression by
blocking antigen presentation to T cells [14,15] and the maturation
of macrophage phagosomes [16]. The signal sequence (s1a, s1b,
s1c, s2) and the middle region (m1, m2) of vacA vary among H.
pylori strains, with strains carrying the vacAs1m1 genotype
considered the most pathogenic subtype [17].
Among cag-PAI genes, the most studied is cagA. This gene is
located on the right half of cag-PAI. It encodes a protein (CagA) that
is injected into the cytoplasm of the host cell and induces cell
morphologic alterations, proliferation, adhesion and apoptosis
[18–20]. The right half of cag-PAI also contains a gene known as
cagE. This gene encodes a protein responsible for the induction of
interleukin (IL)-8, produced by the gastric epithelial cells [21]. It is
considered by same authors to be the best marker of cag-PAI
[22,23]. Additionally, another cag-PAI gene, virB11, can be an
important potential virulent factor, since it is located at a crucial
point of the secretory apparatus system and exhibits ATPase
activity, assisting in the transport of CagA into the host cell [24,25].
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used as a marker of the integrity of this side of the island.
Although several studies have described an association
between H. pylori vacA s1m1 and cagA with gastritis, duodenal
ulcers, peptic ulcers and gastric cancer, the relation between these
genes with malignancy is still controversial. In Western popula-
tions, cagA-positive strains are more commonly associated with
peptic ulceration, atrophic gastritis and gastric adenocarcinoma
than cagA-negative strains [8,26]. However, this relationship is not
observed in many high gastric cancer populations, including in East
Asia, where almost all strains are cagA-positive. Also, in Brazil, the
studies analyzing vacAs1m1 and cagA association have described
conﬂicting results [27–32].
A relevant point is that some studies which have associated
gastric cancer with H. pylori were done without considering the H.
pylori genotypes in the context of the histological subtypes [31,33].
Also, reports of the association of H. pylori with histological types of
gastric cancers are controversial; some studies have shown an
association between H. pylori and intestinal type [34,35], while
others have observed a balanced distribution between the two
histological types [36,37]. Therefore, the aim of this study was to
investigate the frequency and the relevance of the association of
vacA alleles, cagA, cagE and virB11 genes of H. pylori isolated from
patients with gastric cancer, considering the clinical histopatho-
logical parameters.
2. Materials and methods
2.1. Clinical specimens
The present study was approved by the Ethics Committee of the
Hospital Complex of the Federal University of Ceara´ and all
subjects signed the informed consent form before inclusion.
Samples from one hundred and one patients with gastric
adenocarcinoma who had undergone gastrectomy were collected
from two hospitals in Ceara´ State, Brazil: Walter Cantı´deo Hospital
at the Federal University of Ceara´ and Santa Casa de Miserico´rdia
Hospital, both located in Fortaleza, the state capital. The
histological classiﬁcation was made according to the Lauren
classiﬁcation and the tumors were staged according to the TNM
criteria by two pathologists of the team.
2.2. DNA extraction
Genomic DNA was extracted from frozen tumor tissue using the
cetyltrimethyl ammonium bromide (CTAB) technique, adaptedTable 1
PCR primer sets, annealing temperature and size of the PCR products used for genotyp
Gene Primer sequence 
ureC F – 50-AAGCTTTTAGGGGTGTTAGGGGTTT-30
R – 50-AAGCTTACTTTCTAACACTAACGC-30
vacA 
s1/s2 F – 50-ATGGAAATACAACAAACACAC-30
R – 50-CTGCTTGAATGCGCCAAAC-30
m1 F – 50GGTCAAAATGCGGTCATGG30
R – 50-CCATTGGTACCTGTAGAAAC-30
m2 F – 50-GGAGCCCCAGGAAACATTG-30
R – 50-CATAACTAGCGCCTTGCAC-30
cagA F – 50-ATAATGCTAAATTAGACAACTTGAGCGA-30
R – 50-TTAGAATAATCAACAAACATAACGCCAT-30
cagE F – 50-TTGAAAACTTCAAGGATAGGATAGAGC-30
R – 50-GCCTAGCGTAATATCACCATTACCC-30
virB11 F – 50-TTAAATCCTCTAAGGCATGCTAC-30
R – 50-GATATAAGTCGTTTTACCGCTTC-30from the method of Foster and Twell [38]. The DNA extraction was
done only in fragments that showed more than 80% of tumor cells,
and the quality was analyzed by 1% agarose gel electrophoresis
with ethidium bromide staining. Also, the amount of DNA was
determined using the NanoDropTM 3300 ﬂuorospectrometer.
2.3. Detection of H. pylori and the presence of vacA, cagA, cagE and
virB11 genes
The H. pylori infection was detected by ampliﬁcation of the
urease C gene using primers for PCR, as described by Lage et al. [39].
For the H. pylori-positive samples, the presence of the vacA and
alleles, cagA, cagE and virB11 genes were identiﬁed using the
primer sets from the published literature. These are shown in Table
1. PCR mixtures, for ampliﬁcation of cagE and virB11 genes, were
prepared in a volume of 20 mL using MasterMix1 (Taq DNA
Polymerase, dNTPs and MgCl2) according to the manufacturer’s
instructions (Promega1), with addition of 0.8% Tween 20; 0.3 mM
(virB11), 1 mM (cagE) of each primer and 100 ng of the DNA
sample.
The cagA, vacA s1/s2, vacA m1 genes were ampliﬁed in a 25 mL
volume containing 2.5 mL of 10 PCR buffer (Invitrogen1, Cergy
Pontoise, France); 1% Tween 20, 1.5 mM of MgCl2 (Invitrogen1),
200 mM (each) of dNTPs (Invitrogen1), 1 U of Platinum Taq
polymerase (Invitrogen1); 0.4 mM (ureC, cagA, vacA s1/s2, vacA
m1), 0.3 mM (vacA m2) for each primer and 100 ng of H. pylori DNA.
The PCR products were analyzed by 1% agarose gel electropho-
resis with ethidium bromide staining. The size of the ampliﬁcation
product was used to conﬁrm the identity of the PCR product. The
sample was considered H. pylori positive when an ureC fragment of
294 bp was ampliﬁed. For conﬁrmation of the speciﬁcity of
reaction, PCR products from urease C gene were cloned with TOPO
TA Cloning Kit (Invitrogen1) and sequenced using the ABI PRISM1
BigDye Terminator v.3.0 Cycle Sequencing Kit (Applied Biosys-
tems) and ABI Prism 3100 DNA Sequencer (Applied Biosystems).
vacA, cagA, cagE and virB11 genes were considered positive when a
speciﬁc fragment were detected (Table 1). DNAse-free water was
used as a negative control. DNA preservation has also been
conﬁrmed by ampliﬁcation of different genes in other approaches
under study in the laboratory. Random samples were reanalyzed
for conﬁrmation of the results.
2.4. Statistical analyses
These were carried out using the statistical programs SPSS1
version 15.0 (Chicago, IL, USA). Statistically signiﬁcant differencesing H. pylori. F – follow; R – reverse.
Annealing Size of PCR product Reference
55 8C 294 bp [39]
[17]
55 8C 259/286 bp
55 8C 290 bp
52 8C 192 bp
56 8C 297 bp [40]
50 8C 509 bp [23]
49 8C 491 bp [23]
Table 2
Frequency of H. pylori genes.
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analyzed by Spearman’s rank correlation coefﬁcient. The results
were considered statistically signiﬁcant when p-values were less
than 0.05.
3. Results
Among the 101 analyzed cases, 68 (67.3%) were males and 33
(32.7%) females. The average age was 62.7, ranging from 23 to 90
years old. H. pylori infection was detected in 94 out of 101 (93%)
gastric adenocarcinomas. The males were more frequent (68%) in
the H. pylori (+) cases. The rate of H. pylori infection in the antrum
was statistically higher (p < 0.001) than the cardia and body
(53.2%, 26.6% and 17%, respectively). Among H. pylori positive
cases, the intestinal and diffuse histological subtype had similar
frequency, although the intestinal type was slightly more frequent
(58.5% and 41.5%, respectively).
3.1. Relationship between H. pylori infection and vacA, cagA, cagE and
virB11 genes with gastric adenocarcinoma
The frequency of H. pylori genes is show on Table 2. The
frequency of vacAs1m1 associated with cagA was 56.4%. Consider-
ing the integrity of cag-PAI and the association among the cag-PAI
genes, we found a positive correlation between cagA and virB11
(r = 0.229, p = 0.027*), and between cagE and virB11 (r = 0.728**;
p < 0.001). In 6.4% (6/94) of the cases only the cagA and virB11
strains were present, while only cagE and virB11 were present in
11.7% (11/94) of the cases.
Most of the H. pylori strains cagA(+) were associated with
cagE(+) (62.3%). To investigate the relationship between H. pylori
infection and the presence of vacA alleles, cagA, cagE and virB11
genes in gastric tumorigenesis, the cases were divided into three
groups according to vacA alleles and each one was then subdivided
into four subgroups according to the integrity of cag-PAI,
considering the studied genes, the cases which no presented
any cag-PAI genes were classiﬁed as cag-PAI (). These groups,
their frequencies and histological types are shown in Table 3.
No statistical difference was found between intestinal and
diffuse histological types and the H. pylori groups. The most
frequent subgroup in all adenocarcinomas cases was A1 (vacA
s1m1, cagA, cagE and virB11), which represented 36.2% (34/94) of
H. pylori infected gastric cancer cases. There was a statistically
signiﬁcant difference in the frequency of cases found in the A1
group and the other groups: A2 (p = 0.002), A3 (p = 0.001), A4
(p = 0.026), B3 (p = 0.038). Also, comparing the A1 against the BTable 3
H. pylori infection cases in gastric cancer divided according to H. pylori genotypes and 
Groups Histological t
n = 94 
Group A: vacAs1m1 71/94 (75.5%
A1: cagA(+) and cagE(+) and virB11(+) 34/94 (36.2%
A2: cagA(+) and virB11(+) or cagE(+) and virB11(+) 14/94 (14.9%
A3: cagA(+) or cagE(+) or virB11 (+) or cagA(+) and cagE(+) 15/94 (16%) 
A4: cag-PAI () 08/94 (8.5%) 
Group B: vacAs1m2 e vacAs2m1 17/94 (18.1%
B1: cagA(+) and cagE(+) and virB11(+) 02/94 (2.1%) 
B2: cagA(+) and virB11(+) or cagE(+) and virB11(+) 02/94 (2.1%) 
B3: cagA(+) or cagE(+) or virB11 (+) or cagA(+) and cagE(+) 07/94 (7.4%) 
B4: cag-PAI () 06/94 (6.4%) 
Group C: vacAs2m2 06/94 (6.4%)
C1: cagA(+) and cagE(+) and virB11(+) 00/94 (0%) 
C2: cagA(+) and virB11(+) or cagE(+) and virB11(+) 01/94 (1.1%) 
C3: cagA(+) or cagE(+) or virB11 (+) or cagA(+) and cagE(+) 02/94 (2.1%) 
C4 cag-PAI () 03/94 (3.2%) group (all B sub-groups together, since the number of cases were
insufﬁcient for individual statistical analysis), the A1 group was
statistically more frequent (p = 0.001) than the B group. Consider-
ing the H. pylori A groups with at least one marker in the right and
left side of cag-PAI (A1 and A2 groups), a signiﬁcant number of the
cases were included (51%; 48/94), with a statistically signiﬁcant
difference when compared to the A3 (p < 0.001), A4 (p = 0.003), B3
(p = 0.005) and B4 (p = 0.010) groups.
In almost all groups, the predominant anatomical site was the
gastric antrum. In the H. pylori groups (other than group A) in
which it was possible to do statistical analysis, a signiﬁcant
difference was found between group A3 and the presence of the
tumors in the cardia region (8/15; p = 0.015). Interestingly, of all
gastric cancers located in the cardia, 70.8% (17/24) belonged to the
intestinal subtype.
Fig. 1 shows the distribution of the H. pylori genotype groups
according to the tumor stages. Due to a small number of cases, the
subgroups of groups B and C were not considered. From this ﬁgure,
it is possible to observe that the A1 group was present in almost all
stages and also was the most frequent except the III tumor stage.
Although groups A4, B and C were present in almost all stages, they
were less frequent in the majority of the grades. We did not
carefully analyze other risk factors, like alcohol consumption and
smoking, due of the difﬁculties of measuring the levels of exposure.
However, we observed that these factors were frequent in this
group, since 5/6 cases had at least one such associated risk factor.
Figs. 2 and 3 show the distribution of the H. pylori genotype
groups according to tumor stage and histological subtypes. As in
Fig. 1, all cases of B and C subgroups are shown together. In both
histological subtypes it is possible to observe that the A1 group was
present from earlier stages with high frequency. Although in the
diffuse tumors the frequencies of the A1 and A2 groups increased
with tumor stage, in the intestinal subtype there was a decrease in
the frequency of the A1 subgroup in grades III and IV. Even whenhistological types.
ypes
Intestinal (n = 55) Diffuse (n = 39) P value
)
) 21/55 (38.2%) 13/39 (33.3%) p= 0.630
) 8/55 (14.5%) 6/39 (15.4%) p= 0.910
10/55 (18.2%) 5/39 (12.8%) p = 0.484
3/55 (5.5%) 5/39 (12.8%) p = 0.207
)
1/55 (1.8%) 1/39 (2.6%) p = 0.805
1/55 (1.8%) 1/39 (2.6%) p = 0.805
5/55 (9.1%) 2/39 (5.1%) p = 0.471
4/55 (7.3%) 2/39 (5.1%) p = 0.675
0/55 (0%) 0/39 (0%) -
0/55 (0%) 1/39 (2.6%) p = 0.223
1/55 (1.8%) 1/39 (2.6%) p = 0.805
1/55 (1.8%) 2/39 (5.1%) p = 0.386
Fig. 1. Distribution of H. pylori genotype groups A, B and C according to the tumor stages.
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The distribution of the H. pylori groups by gender shows that
women were more frequent than men in the A1 (56.2%  43.8%)
and A2 (26%  16.7%) groups. However, this sex ratio was reversedFig. 3. Distribution of H. pylori genotype groups A, B and C in the diffuse cases
according to the tumor stages.
Fig. 2. Distribution of H. pylori genotype groups A, B and C in the intestinal cases
according to the tumor stages.in the A3 (25%  13%) and A4 (14.5%  4.8%) groups, but without
statistical signiﬁcance.
It is interesting to note that the C4 genotype group was
signiﬁcantly more frequent (p < 0.001) in the younger patients (up
to 44 years old, six cases) than the oldest ones and ﬁve of them
were in the diffuse type, but no family history was described.
Additionally, the A3 group was associated with the older patients,
those above 65 years old (p = 0.018).
4. Discussion
The association of gastric cancer with H. pylori has been well
established [41]. Some aspects, like host genetic proﬁle, lifestyle
can explain the gastric carcinogenesis, but the bacterial genotype
seems to have a relevant role [13]. H. pylori strains have substantial
phenotypic and genotypic diversity, which may engender individ-
ual host inﬂammatory responses that inﬂuence clinical outcome
[42–44]. The well established virulence factors, vacA alleles (s1m1)
and cagA, although having an impact on bacterial pathogenesis,
cannot explain all gastric cancer development. Therefore, other
potential virulence factors need to be investigated. In this respect,
cagE and virB11 genes are interesting since they belongs to the cag-
PAI and have an important role [21–25] and along with cagA could
be markers of the pathogenic strain for gastric cancer develop-
ment.
As expected, a close association of gastric cancer with H. pylori
infection was observed in this study. Similar frequencies observed
in this study (93%) have been found in other Brazilian studies from
the southeast region, and in studies from Turkey and Hawaii
[28,36,45–48]. As in other studies, the most frequent mosaic of the
vacA gene found in our study was vacA s1m1 (75.5%). This ﬁnding
is consistent with the pathogenic aspect of this gene, since the
production of VacA toxin is related to the allelic structure, where
the s1m1 and s1m2 genotype strains are high and moderate,
respectively, producers of VacA protein, whereas s2m2 genotype
strains do not produce VacA. Also, s1/m1 is toxic to a wider range of
epithelial cells than s1/m2 [49].
A relatively high frequency (64.9%) of H. pylori-infected gastric
cancers were infected by the cagA(+) variety. The frequency of cagA
is diverse according to region and associated disease. In Eastern
countries, almost all H. pylori strains are cagA positive (88.9% and
88.4%); and therefore the presence of this gene is not related to
gastrointestinal diseases [50,51]. On the other hand, in Western
countries the frequency of the cagA variety is between 26.4% and
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the development of more severe gastric diseases, including gastric
cancer [47,52,53]. In Brazilian studies, a great variation is also
reported (54.7–100%) of association with gastric cancer cases
[54,55]. There are suggestions that the regional divergence could
be due of polymorphism in the cagA gene, but this subject is not
fully elucidated.
An association between H. pylori strains carrying vacAs1m1 and
cagA genes has been related with clinical outcome in some studies,
but the pathogenicity of these strains is still controversial. Also,
there is a little knowledge about the interaction between these two
genes and the gastric cancer development. Recently, Yokoyama
et al. [56] proposed a mechanism based in the opposite effects of
these genes on the nuclear factor of activated T cells (NFAT). They
demonstrated that CagA activates NFAT, which in turn activates
many genes, including p21, a cell cycle inhibitor. Conversely, they
demonstrated that VacA counteracts this activation. Therefore, the
nuclear activation of NFAT by CagA is counteracted by the presence
of VacAs1m1, reducing the p21 induction and thus stimulating
deregulated cell growth. Since H. pylori-injected CagA also
deregulates SHP-2 and other cellular target molecules that
promote cell proliferation, this process could lead to transforma-
tion in gastric epithelial cells and, therefore, explain the association
of these genes with the pathogenic process and the high frequency
of these associations found in this study.
Despite the importance of cagA and vacA s1m1 genes for
bacterial virulence, they do not appear sufﬁcient for gastric cancer
development. So other H. pylori cag-PAI genes must be involve due
of the importance for the functionality of type IV system secretion.
Additionally, these genes could work, along with cagA, as markers
for cag-PAI integrity. Studies of cag-PAI integrity associated with
diseases are controversial because there are no patterns for the
selected genes [22,23,57,58]. In the present study, we did not
analyze the composition of cag-PAI was in depth. We chose the
genes based for their location on the island as well as on the
putative role of their proteins.
The importance of cagE can be observed by its high frequency in
gastric cancer from India (100%), Turkey (81.8%) and Thailand
(93.8%) [51,59,60]. In the present study, 53.2% the cases had H.
pylori that were cagE positive, which is lower than reported in
these other studies. Also, cagE has been suggested as a better
marker for the integrity of cag-PAI than cagA [23,33]. Interestingly,
in our study, although cagA was more frequent than cagE, most of
the time it was associated with cagE. Therefore, our data
corroborate the suggestion that cagA is a better single marker of
the pathogenicity island. However, the association with cagE
improved the accuracy, suggesting the use of both as markers for
cag-PAI presence and also for the pathological signiﬁcance of these
genes.
In addition to cagE, virB11 was found in a signiﬁcant (60.6%)
number of the gastric cancer cases analyzed. So far, there are no
studies linking the presence of gastric cancer to virB11. Neverthe-
less Tomasini et al. [61] and Sozzi et al. [23] studied Italian
dyspeptic patients and found 90% and 94.7% presence, respectively,
of the virB11 gene.
To verify the most frequent H. pylori genotype in gastric cancer
and their contribution to the development of gastric cancer, we
divided the cases according to vacA alleles and cag-PAI integrity.
According this distribution, we found that the vacAs1m1 plus all
cag-PAI genes studied (A1) was the most frequent genotype
(36.2%), which was considered the most pathogenic genotype in
this study. Additionally, considering the cag-PAI integrity using
cagA and/or cagE as right side markers (A1 + A2), 51% of the cases
were included. Since gastric cancer is expected to result from more
virulent strains, the combination genotypes presented in this study
suggests that cagE and virB11 genes were involved in gastriccarcinogenesis. Also, virB11 could be used as left marker for cag-
PAI. Also, the signiﬁcant frequency of more virulent strains in all
tumor stages, include the early stage, indicates the importance of
these H. pylori strains to gastric carcinogenesis. The low frequency
of early stage cases found in this study is explained by the fact that
the samples were taken from patients treated by the public health
system, in which low-income individuals who seek hospitals when
the disease is already in its advanced stages predominate.
In this study, the frequency of H. pylori A1 and A2 strains did not
differ between the intestinal and diffuse histological types,
corroborating the suggestion of H. pylori’s involvement in both
tumor subtypes [36,37,62,63]. Interestingly, we observed an
increase in frequency of these groups with malignancy in the
diffuse tumors, while in the intestinal tumors the highest
frequencies were in the early stage, suggesting that H. pylori is
involved in gastric carcinogenesis independently of the histologi-
cal subtype, although having different carcinogenic pathways.
The gastric cancer cases located in the antrum were predomi-
nant in patients infected with more pathogenic strains of group A,
corroborating with some studies that have reported that H. pylori
strains were associated with the gastric antrum [64]. Noteworthy,
same less virulent strain was related to gastric cardia (A3 and B4)
and body (C2 and C4). This fact can be related to associate risks,
such as alcohol consumption (at least 400 mL a day) and smoking
(at least 2 box a day) in patients infected by less virulent strains. In
fact, 53.8% of patients with less virulent strains were smokers and
drinkers.
In conclusion, this study allowed verifying that cag-PAI genes in
association with vacAs1m1, are potentially important H. pylori
strain markers for gastric cancer development, since this strain was
the most frequent and was present from the initial tumorigenic
process. The H. pylori strains seem to be important for gastric
cancer development in both histological subtypes, but probably act
through different carcinogenic pathways. The presence of less
virulent strains in gastric cancer could be because of the
association with host genetic predisposition; other risk factors
like smoking and drinking or some other bacterial factors that were
not analyzed in this study. Also, this study corroborates the
importance of cagA as a marker for cag-PAI, but the association
with cagE seems a better marker in this respect and also suggests
virB11 as a left side cag-PAI marker.
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